Furthermore, A study based on RNA-seq and network pharmacological analysis showed that SXNI effectively protects heart from injuries via a common Tnfrsf12a-mediated pathway involving atherosclerosis signaling and inflammatory response (Lyu et al., 2018). Here, TNFRSF12A is linked to atherosclerosis.